Continuous cardiorespiratory monitoring
Including:
- ECG
- Blood pressure
- Oxygen saturations
We are pleased to advise that deep linking capability, enabling users to directly download individual mobile toolkits, has now been released on the RDS mobile app. When you install the update, you will see that each toolkit has a small QR code icon the header area beside the search icon – see screenshot below. Clicking on this icon will open up a window with a full-size QR code and the alternative of a short URL for sharing with users. Instructions are provided.
You may need to actively install the update to install RDS app version 4.7.1 to see this improvement. Installing this update is also strongly recommended to get the full benefits of the new contingency arrangements – specifically, that if the RDS website should fail, you will still be able to download new mobile app toolkits.
To check your current RDS version, click on the three dots bottom right of the RDS app screen. This takes you to a “More” page where you will see the version number. To install latest updates:
On iPhones – go to the Apple store, click on your profile icon top right, scroll down to see the apps waiting to be updated and update the RDS app.
On Android phones – these can vary, but try going to the Google Play store, click on your profile icon top right, click on “Manage apps and device”, select and update the RDS app.
Please get in touch with ann.wales3@nhs.scot with any questions.
To provide a guideline for the use of Isoprenaline Hydrochloride in paediatric complete heart block.
This guideline is intended for all healthcare professionals involved in the care of paediatric patients with complete heart block who require treatment with Isoprenaline Hydrochloride.
For neonatal guidance refer to the West of Scotland NEONATAL Parenteral Drug Monographs
Background:
Preparations:
Isoprenaline Hydrochloride Injection 1mg/5ml
Dose:
IV Infusion Dose for Complete Heart Block2:
IV Infusion: 0.1-1micrograms/Kg/minute
Infusion rate to be titrated according to clinical response. Dose may be increased every 2-3 minutes until appropriate response obtained as directed by Consultant Cardiologist.
Route of administration3:
Continuous intravenous infusion, preferably via a central line.
Isoprenaline has a low PH and may cause venous irritation and tissue damage in cases of extravasation.
If a central line is not available, administer via a large peripheral vein.
Dilution3:
Diluent : Glucose 5% (preferred) or Nacl 0.9%
Line |
Maximum Concentration |
PERIPHERAL |
20micrograms/ml |
CENTRAL |
60micrograms/ml |
Peripheral line: Add 1mg (5mls) Isoprenaline hydrochloride to 45mls of diluent to make a final concentration of 1mg/50ml (20micrograms/ml)
If requiring doses greater than 25mls/hour:
Prepare an infusion of 10mg Isoprenaline hydrochloride in 500mls diluent
Central line: Add 3mg (15ml) Isoprenaline to 35mls of diluent to make a final concentration of 3mg/50ml (60micrograms/ml)
If requiring doses greater than 25mls/hour:
Prepare an infusion of 30mg (150mls) Isoprenaline hydrochloride in 350mls diluent
To calculate infusion rate:
Continuous cardiorespiratory monitoring
Including: